Asphalion is the regulatory partner for a successfully funded Horizon 2020 project entitled “Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications, antimicrobial drug resistance, and unresponsiveness to therapeutic HIV-1 vaccination”, MISTRAL.
With a budget of ten million euros the scientists will analyse the role of the intestinal microbiome in HIV infection with the objective of designing treatments to prevent HIV infection, reinforce the immune system, control the progression of the infection and improve the response to potential vaccinations against the virus.
This 5-year project has been granted under the H2020 call: Stratified host-directed approaches to improve prevention, treatment and/or cure of infectious diseases.
More details about the project: https://cordis.europa.eu/project/id/847943
Asphalion is proud to participate in the consortium and is looking forward to begin this challenging collaboration with all partners.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 847943